HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 10 of 45
Relies on extensive experience in leadership positions in institution, independent, and governmental Institutional Review Boards to support investigators while they navigate multicenter research studies.
Promoting collaboration between academia and industry by developing relationships with other institutions, biotechnology, pharmaceutical, and medical device companies to continue research and to commercialize CHOP research discoveries and technology-based ventures.
The research in the Sabatino Laboratory is focused on hemophilia, an inherited bleeding disorder. The interests of the laboratory include the study of variants of coagulation factor VIII to understand the biochemical properties of these proteins and to identify novel variants with enhanced function, and the development of gene-based therapeutic approaches for treating hemophilia.
Dr. Schultz's research involves using magnetic resonance imaging to understand brain mechanisms and to create biomarkers that predict who has autism spectrum disorder (ASD), who will develop the disorder, and who will respond well to different interventions. More recently, he has developed a technology and innovation lab to exploit advances in perceptual computing, in order to develop more robust measurements of quantitative traits.